Letters, Testimony & Comments
BIO commends the government of Colombia for taking steps towards developing regulatory requirements for the registry of medicines of...
February 22 2013
BIO commends the INPI for their efforts to devise guidelines for examining biotechnology related inventions. Given the technological...
February 1 2013
BIO respectfully submits both questions and comments for the National Health Surveillance Agency’s (ANVISA) consideration on the...
February 1 2013
From BIO’s perspective, Supplemental Examination may have significant benefits, because patents that undergo this process are...
March 25 2012
Selected Excerpts:
The vast majority of BIO’s members are small and medium sized enterprises that currently do not have products...
March 7 2012
January 30, 2012
Azam Khan
Deputy Chief of Staff,
Office of the Under Secretary and Director
United States Patent and...
January 30 2012
June 14, 2011
Dear Chairman Smith:
On behalf of the Biotechnology Industry Organization (BIO), I am writing to express our strong support for your...
June 14 2011
June 13, 2011
Dear Speaker Boehner and Leader Pelosi:
We write to express our unified support for Section 22 of H.R. 1249, “The America Invents...
June 13 2011
April 1, 2011
Re: Request for Comments on the Strategy for American Innovation
Subject: Innovation Strategy RFI
Email: competitiveness@doc.gov
Dear...
April 1 2011
March 24, 2011
March 24, 2011
As our economy begins to improve, job creation remains a critical priority toward ensuring a broad, deep and sustained...
March 24 2011
April 30, 2009
Written Testimony of
The Biotechnology Industry Organization (BIO)
Before the United States House of Representatives...
April 30 2009
April 2, 2009
BIO commends the Senate Judiciary Committee for its success in developing a more consensus-oriented approach to patent reform legislation...
April 2 2009
March 10, 2009
Written Testimony of
The Biotechnology Industry Organization (BIO)
Before the United States Senate
Committee on the...
March 10 2009
October 13, 2008
BIO responds to a recent report entitled "Toward a New Era of Intellectual Property: From Confrontation to Negotiation" which offered no...
October 13 2008
June 6, 2007
Chairman Leahy, Ranking Member Specter, and Members of the Committee, I am pleased to testify before you today on the critically important...
June 6 2007
April 26, 2007
The Statement of the The Biotechnology Industry Organization On H.R. 1908, The Patent Reform Act of 2007
The United States House of...
April 26 2007
October 6, 2006
October 6 2006
January 21, 2004
January 21 2004
October 24, 2003
Dear House Leadership:
On behalf of the Biotechnology Industry Organization (BIO), I urge you to seek prompt passage of H.R. 1561, the...
October 24 2003
September 8, 2003
Earlier this year both the House and Senate passed their versions of a Medicare reform bill /1. Included in both the House and Senate...
September 8 2003
October 2, 2002
Dear Senator Daschle:
The Biotechnology Industry Organization (BIO) strongly supports the Conference Agreement on the Department of Justice...
October 2 2002
September 20, 2002
Letter from BIO to the U.S. House of Representatives strongly urging members not to sign the discharge petition (H. Res. 517) offered by...
September 20 2002
July 15, 2002
Expressing strong concerns regarding S. 812 (McCain/Schumer- Edwards/Collins)
July 15 2002
June 14, 2002
The Honorable Thomas A. Daschle
509 Hart Senate Office Building
Washington, DC 20510
Dear Majority Leader Daschle:
...
June 14 2002
March 21, 2002
Ranking Member of the House Judiciary Committee
March 21 2002
March 21, 2002
Chairman of the House Judiciary Subcommittee on Courts, The Internet, and Intellectual Property
March 21 2002
March 21, 2002
Ranking Member of the House Judiciary Subcommittee on Courts, The Internet, and Intellectual Property
March 21 2002
February 26, 2002
The biotechnology industry is the most research and development intensive and capital-focused industry in the world. As such, it is very...
February 26 2002
July 26, 2001
Honorable Michael Bilirakis
Chairman
Subcommittee on Health
Committee on Energy and Commerce
U.S. House of Representatives
2125...
July 26 2001
May 10, 2001
Executive Summary
The Biotechnology Industry Organization (BIO) supports amendment of the current reexamination authority to enhance patent...
May 10 2001
July 1, 1999
Executive Summary
The Biotechnology Industry Organization (BIO) supports reforms of the Hatch Waxman Act that will provide full day-for-...
July 1 1999
March 25, 1999
Executive Summary
BIO supports amendments to the patent law that, above all, ensure that diligent patent applicants are not penalized...
March 25 1999
Dear Senators Reid and McConnell:
On behalf of the more than 430 undersigned organizations representing American innovation
from all 50...
Letters, Testimony & Comments
February 22 2013
BIO commends the government of Colombia for taking steps towards developing regulatory requirements for the registry of medicines of...
February 1 2013
BIO commends the INPI for their efforts to devise guidelines for examining biotechnology related inventions. Given the technological...
February 1 2013
BIO respectfully submits both questions and comments for the National Health Surveillance Agency’s (ANVISA) consideration on the...
March 25 2012
From BIO’s perspective, Supplemental Examination may have significant benefits, because patents that undergo this process are...
March 7 2012
Selected Excerpts:
The vast majority of BIO’s members are small and medium sized enterprises that currently do not have products...
Press Releases
September 8 2011
Washington, D.C. (September 8, 2011) – Biotechnology Industry Organization (BIO) President and CEO Jim...
June 23 2011
WASHINGTON, D.C. (Thursday, June 23, 2011) - Biotechnology Industry Organization (BIO) President and CEO Jim...
June 21 2011
WASHINGTON, D.C. (Tuesday, June 21, 2011) - Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood...
May 3 2011
WASHINGTON, D.C. (Tuesday, May 03, 2011) - The Biotechnology Industry Organization (BIO) announced today its...
April 15 2011
WASHINGTON, D.C. (Friday, April 15, 2011) - Biotechnology Industry Organization (BIO) President and CEO Jim...
Receive our newsletter from BIOtechNOW
Business Solutions Sponsor
